Home › NDC Lookup › RxCUI directory › RxCUI 2390650

Enzalutamide 80 MG Oral Tablet [Xtandi] — RxCUI 2390650

RxNorm drug concept · Semantic branded drug
RxCUI 2390650 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2390650
Official nameEnzalutamide 80 MG Oral Tablet [Xtandi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXtandi 80 MG Oral Tablet
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)9,669 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Enzalutamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Enzalutamide — sold as Xtandi — is approved for treating prostate cancer at different stages. It's used when the cancer is still sensitive to hormone therapy (castration-sensitive)...
  • What exactly is enzalutamide being used to treat in my case?
  • You can take Xtandi with or without food — it doesn't make a meaningful difference in how well the drug is absorbed. What matters most is that you take it at roughly the same time...
  • Does it matter when I take it or whether I take it with food?
📖 Read our full Enzalutamide guide →

🕸️ Concept Web — How Enzalutamide 80 MG Oral Tablet [Xtandi] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Enzalutamide 80 MG Oral Tablet [Xtandi] RxCUI 2390650

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Enzalutamide 1307298
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xtandi 1307304
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Enzalutamide Oral Tablet 2390643
    • Enzalutamide Oral Product 1307300
    • Enzalutamide Pill 1307301
    • Enzalutamide Oral Tablet [Xtandi] 2390645
    • Xtandi Oral Product 1307307
    • Xtandi Pill 1307308
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Enzalutamide 80 MG Oral Tablet SCD · 2390648
  • Enzalutamide 80 MG SCDC · 2390647
  • Enzalutamide Oral Tablet SCDF · 2390643
  • Enzalutamide Oral Product SCDG · 1307300
  • Enzalutamide Pill SCDG · 1307301

Brand-Name Concepts

  • Enzalutamide 80 MG [Xtandi] SBDC · 2390649
  • Enzalutamide Oral Tablet [Xtandi] SBDF · 2390645
  • Xtandi Oral Product SBDG · 1307307
  • Xtandi Pill SBDG · 1307308
  • Xtandi BN · 1307304

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2390650 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00469-0125-99 1 BOTTLE in 1 CARTON (0469-0125-99) / 120 CAPSULE in 1 BOTT... Xtandi Astellas Pharma US, Inc. 2012-08-31
00469-0625-99 1 BOTTLE in 1 CARTON (0469-0625-99) / 120 TABLET in 1 BOTTL... Xtandi Astellas Pharma US, Inc. 2020-08-04
00469-0725-60 1 BOTTLE in 1 CARTON (0469-0725-60) / 60 TABLET in 1 BOTTLE Xtandi Astellas Pharma US, Inc. 2020-08-04
00469-1125-56 56 CAPSULE in 1 BLISTER PACK (0469-1125-56) Xtandi Astellas Pharma US, Inc. 2012-08-31
00469-1725-56 1 BOTTLE in 1 CARTON (0469-1725-56) / 56 TABLET in 1 BOTTLE Xtandi Astellas Pharma US, Inc. 2020-08-04
Observed labelers: Astellas Pharma US, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.